Current medical research and opinionHumansFemaleMaleGlucagon-Like PeptidesMiddle Aged
Sustained weight reduction with once-weekly semaglutide: results from a real-world retrospective cohort study in the United States (SCOPE 24 months).
Aleksandrina Ruseva, Wojciech Michalak, Anthony Fabricatore, Bríain Ó Hartaigh, Zhenxiang Zhao, Julia Wang, Devika Umashanker
Published: 202510.1080/03007995.2025.2591464
Abstract
OBJECTIVE: To evaluate the real-world effectiveness of once-weekly semaglutide for weight reduction and change in cardiometabolic risk factors at 24 months in patients with obesity or overweight. METHODS: This real-world retrospective, cohort study u…
Preview only. Read the full abstract at the source